RLMD
NASDAQ · Pharmaceuticals
Relmada Therapeutics Inc
$3.80
+0.03 (+0.80%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+883.4% upside
Low Target
$22.23
Average Target
$37.37
High Target
$43.38
Current Price
$3.80
Current
$3.80
$3.80
Target
$37.37
$37.37
$22.23
$37.37 avg
$43.38
Scenario Analysis
Bear Case
$22.23
485.0%
Low target
Base Case
$37.37
+883.4%
Avg target
Bull Case
$43.38
+1,041.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$8.00
-52.5% from high
52-Week Low
$2.42
+57.0% from low
Target vs 52W High
$37.37
+367.1% vs high
Next Earnings Report
Nov 12, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.15
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals